During the past decade, Universitaetsklinikum EssenZentrum fuer Innere Medizin conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitaetsklinikum EssenZentrum fuer Innere Medizin" #1 sponsor was "Celgene" with 3 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Hannover Medical School" with 1 trials sponsored, "HepNet Study House, German Liverfoundation" with 1 trials sponsored and "Hologic, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitaetsklinikum EssenZentrum fuer Innere Medizin" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "German Center for Infection Research" with 1 trials as a collaborator, "Hannover Medical School" with 1 trials as a collaborator and "HepNet Study House, German Liverfoundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Universitaetsklinikum EssenZentrum fuer Innere Medizin" are "Acute Hepatitis C" (2 trials), "B-cell Chronic Lymphocytic Leukemia" (1 trials), "Chronic HCV Infection" (1 trials), "Chronic Hepatitis B" (1 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "Universitaetsklinikum EssenZentrum fuer Innere Medizin" in a lesser frequency.

Most popular intervention types in "Universitaetsklinikum EssenZentrum fuer Innere Medizin" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Dexamethasone" (1 trials), "Durvalumab" (1 trials), "GED-0301" (1 trials) and "LDV/SOF" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitaetsklinikum EssenZentrum fuer Innere Medizin" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Universitaetsklinikum EssenZentrum fuer Innere Medizin". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Universitaetsklinikum EssenZentrum fuer Innere Medizin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitaetsklinikum EssenZentrum fuer Innere Medizin, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".